Skip to main content
FinSpry Logo
FinSpry
MRNA logo
MRNA
(NASDAQ)
Moderna, Inc.
$48.12-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Moderna (MRNA) Stock Price & Financial Analysis

Moderna Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$47.64 - $50.50
52-Week High$59.55
52-Week Low$22.28
Open$49.98
Volume5.00M
Average Volume (3M)7.40M
Market Cap18.06B
Shares Outstanding395.00M
Price to Sales (P/S)8.12
Price to Book (P/B)2.44
EV/EBITDA-5.49
Revenue (TTM)2.23B
Net Income (TTM)-3.19B
Free Cash Flow (TTM)-1.58B
EPS (TTM)$-8.16
Profit Margin-143.55%
Operating Margin-153.35%
Return on Equity (ROE)-43.12%
Debt to Equity0.08
50-Day MA$51.59
200-Day MA$36.31
52-Week Change105.76%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Moderna

What is the current stock price for MRNA?

As of the latest trading session, MRNA stock trades at $48.11. The 52-week range is $22.28–$59.55, with a day range of $47.64–$50.50.

What is the P/E ratio for MRNA?

The P/E ratio (Price-to-Earnings) for MRNA is shown in the Key Statistics section. This valuation metric helps compare Moderna, Inc. to industry peers.

Does MRNA pay dividends?

Moderna does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MRNA?

Based on 2 analysts, the consensus for MRNA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MRNA?

Moderna's market capitalization is $19.00B, classifying it as a large-cap company. Moderna operates in the Healthcare sector within the Biotechnology industry.